Modulation of plasma cytokines and its association with clinical response to treatment with the JAK2-selective inhibitor SAR302503 in myelofibrosis (MF).
Moshe Talpaz
Consultant or Advisory Role - ARIAD
Research Funding - ARIAD
Catriona H. M. Jamieson
Consultant or Advisory Role - Janssen; Novartis; Sanofi
Nashat Y. Gabrail
Research Funding - Sanofi
Claudia Lebedinsky
Employment or Leadership Position - Sanofi
Feng Liu
Employment or Leadership Position - Sanofi
Hui Cao
Employment or Leadership Position - Sanofi
Ayalew Tefferi
No relevant relationships to disclose
Animesh Dev Pardanani
Research Funding - Bristol-Myers Squibb; Sanofi ; YM BioSciences